Patents Assigned to AnaCardio R&D AB
  • Publication number: 20230346889
    Abstract: The invention provides a ghrelin molecule for use in the treatment and/or prophylaxis of Acute Heart Failure (AHF) in an individual, as well as corresponding methods and uses. The invention further provides associated compositions and kits of parts, for use in the treatment and/or prophylaxis of AHF in an individual.
    Type: Application
    Filed: December 18, 2020
    Publication date: November 2, 2023
    Applicant: AnaCardio R&D AB
    Inventor: Lars H. Lund
  • Publication number: 20230126295
    Abstract: The invention provides a ghrelin molecule for use in the treatment and/or prophylaxis of Acute Heart Failure (AHF) in an individual, as well as corresponding methods and uses. The invention further provides associated compositions and kits of parts, for use in the treatment and/or prophylaxis of AHF in an individual.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 27, 2023
    Applicant: AnaCardio R&D AB
    Inventor: Lars H. Lund